EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single Radial Immunodiffusion (SRID) Assay for Quantitative Determination of Recombinant SOD Protein in a Brucellosis Vaccine Candidate: Method Development and Validation

Gulnur Nakhanova, Olga Chervyakova iD, Kamshat Shorayeva, Aigerim Zhakypbek, Sabina Moldagulova, Aknur Ulankyzy, Alisher Omurtay, Yeraly Shayakhmetov, Temirlan Baiseit, Zharkinay Absatova, Aisha Issabek iD, Gaukhar Shynybekova iD und 10 weitere

Methods and Protocols · 28.07.2026 · 9 (4) · 113

DOI: 10.3390/mps9040113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods and Protocols, online erschienen am 28.07.2026. Verfasst von Gulnur Nakhanova und 21 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant superoxide dismutase (SOD) protein is a promising antigen candidate for brucellosis vaccines, and its quantitative determination is essential for vaccine quality control, standardization, and regulatory compliance. Although enzyme-linked immunosorbent assay (ELISA) is widely used for antigen quantification, its application to vaccine formulations may be limited due to chemical modifications of antigenic determinants occurring during detoxification and adjuvantation processes. Therefore, alternative analytical methods, such as single radial immunodiffusion (SRID), which enable direct antigen quantification independent of antigenic determinant modifications, represent valuable tools for vaccine analysis. The aim of this study was to develop and validate a single radial immunodiffusion (SRID) assay for the quantitative determination of recombinant SOD protein and to obtain hyperimmune sera in sheep. Sheep were immunized with recombinant SOD protein formulated with aluminum hydroxide or AddaS03 adjuvants. Antibody responses were evaluated using agar gel immunodiffusion (AGID) and enzyme-linked immunosorbent assay (ELISA). Immunization with aluminum hydroxide induced higher antibody titers than AddaS03. By day 42, ELISA titers reached 1:25,600 in the aluminum hydroxide group compared with 1:3200 in the AddaS03 group. The obtained hyperimmune sera were used for SRID assay development. The optimized SRID assay demonstrated high reproducibility and specificity, with no cross-reactivity against unrelated proteins. A linear relationship was observed between the square of the precipitation ring diameter (D2) and antigen concentration (R2 = 0.956–0.989). The assay showed a limit of detection of 0.312 μg/mL, a linear range of 0.625–10 μg/mL, high precision (CV < 2%), and robustness under varying analytical conditions. The developed SRID assay represents a specific, reproducible, and robust tool for quantitative control of recombinant SOD protein in vaccine formulations.

Schlagwörter

Stichwörter der Autor:innen

brucellosismethod validationrecombinant proteinssingle radial immunodiffusionvaccine quality control

Autor:innen und Institutionen

  • Research Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
  • School of Pharmacy, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.
  • Limited Liability Partnership "OtarBioPharm", QazBioPharm National Holding JSC, Gvardeiskiy 080409, Kazakhstan.

ORCID-Profile: Olga Chervyakova, Aisha Issabek, Gaukhar Shynybekova, Aziz Nakhanov, Ainar Kossylganova, Assem Kalykova, Tolkyn Bekezhanova, Kuandyk Zhugunissov

Förderung

  • Ministry of Health of the Republic of Kazakhstan

Zitieren

APA

Nakhanova, G., Chervyakova, O., Shorayeva, K., Zhakypbek, A., Moldagulova, S., Ulankyzy, A., Omurtay, A., Shayakhmetov, Y., Baiseit, T., Absatova, Z., Issabek, A., Shynybekova, G., Sadikaliyeva, S., Nakhanov, A., Jekebekov, K., Kossylganova, A., Zhaparkulova, K., Kalykova, A., Bekezhanova, T., …, & Zhugunissov, K. (2026). Single Radial Immunodiffusion (SRID) Assay for Quantitative Determination of Recombinant SOD Protein in a Brucellosis Vaccine Candidate: Method Development and Validation. Methods and Protocols, 9(4), 113. https://doi.org/10.3390/mps9040113

Vancouver

Nakhanova G, Chervyakova O, Shorayeva K, Zhakypbek A, Moldagulova S, Ulankyzy A, et al. Single Radial Immunodiffusion (SRID) Assay for Quantitative Determination of Recombinant SOD Protein in a Brucellosis Vaccine Candidate: Method Development and Validation. Methods and Protocols. 2026;9(4):113. doi:10.3390/mps9040113

BibTeX
@article{Nakhanova2026,
  author = {Nakhanova, Gulnur and Chervyakova, Olga and Shorayeva, Kamshat and Zhakypbek, Aigerim and Moldagulova, Sabina and Ulankyzy, Aknur and Omurtay, Alisher and Shayakhmetov, Yeraly and Baiseit, Temirlan and Absatova, Zharkinay and Issabek, Aisha and Shynybekova, Gaukhar and Sadikaliyeva, Sandugash and Nakhanov, Aziz and Jekebekov, Kuanysh and Kossylganova, Ainar and Zhaparkulova, Karlygash and Kalykova, Assem and Bekezhanova, Tolkyn and Atakanova, Albina and Yershebulov, Zakir and Zhugunissov, Kuandyk},
  title = {Single Radial Immunodiffusion (SRID) Assay for Quantitative Determination of Recombinant SOD Protein in a Brucellosis Vaccine Candidate: Method Development and Validation},
  journal = {Methods and Protocols},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {113},
  doi = {10.3390/mps9040113}
}
Kostenlos starten →